Should addiction researchers be interested in psychedelic science?
- 10 April 2017
- journal article
- Published by Wiley in Drug and Alcohol Review
- Vol. 36 (3) , 285-287
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up studyJournal of Psychopharmacology, 2012
- A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)Journal of Psychopharmacology, 2012
- Integrated Exposure-Based Therapy for Co-occurring Posttraumatic Stress Disorder and Substance DependenceJAMA, 2012
- Prevalence of post-traumatic stress disorder among patients with substance use disorder: it is higher than clinicians think it isEuropean Journal of Psychotraumatology, 2012
- Examining potential contraindications for prolonged exposure therapy for PTSDEuropean Journal of Psychotraumatology, 2012
- Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of opennessJournal of Psychopharmacology, 2011
- The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyJournal of Psychopharmacology, 2010
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months laterJournal of Psychopharmacology, 2008
- Posttraumatic Stress Disorder in the National Comorbidity SurveyArchives of General Psychiatry, 1995
- Subjective Reports of the Effects of MDMA in a Clinical SettingJournal of Psychoactive Drugs, 1986